Follow-up of Bernese Mountain dogs and other dogs with serologically diagnosed Borrelia burgdorferi infection: what happens to seropositive animals? by Gerber, B et al.
University of Zurich
Zurich Open Repository and Archive
Winterthurerstr. 190
CH-8057 Zurich
http://www.zora.uzh.ch
Year: 2009
Follow-up of Bernese Mountain dogs and other dogs with
serologically diagnosed Borrelia burgdorferi infection: what
happens to seropositive animals?
Gerber, B; Haug, K; Eichenberger, S; Reusch, C E; Wittenbrink, M M
Gerber, B; Haug, K; Eichenberger, S; Reusch, C E; Wittenbrink, M M (2009). Follow-up of Bernese Mountain dogs
and other dogs with serologically diagnosed Borrelia burgdorferi infection: what happens to seropositive animals?
BMC Veterinary Research, 5:18.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
BMC Veterinary Research 2009, 5:18.
Gerber, B; Haug, K; Eichenberger, S; Reusch, C E; Wittenbrink, M M (2009). Follow-up of Bernese Mountain dogs
and other dogs with serologically diagnosed Borrelia burgdorferi infection: what happens to seropositive animals?
BMC Veterinary Research, 5:18.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
BMC Veterinary Research 2009, 5:18.
Follow-up of Bernese Mountain dogs and other dogs with
serologically diagnosed Borrelia burgdorferi infection: what
happens to seropositive animals?
Abstract
BACKGROUND: Data on the long-term outcome of B. burgdorferi infections in adult dogs are sparse.
The aim of the present study was to investigate whether Bernese Mountain dogs with serological
evidence of natural B. burgdorferi infection more often develop signs such as lameness, azotemia or
proteinuria during a follow-up period of 2.5 to 3.0 years. Seropositive Bernese Mountain dogs were
compared to seronegative Bernese Mountain dogs and to seropositive and seronegative control dogs of
other breeds. Dogs included in a previous study on the prevalence of antibodies against B. burgdorferi in
Bernese Mountain dogs were re-evaluated. Antibodies against B. burgdorferi were determined using an
ELISA with a whole-cell sonicate as antigen and results were confirmed using a Western blot assay.
RESULTS: Fifty-three Bernese Mountain dogs and 30 control dogs were re-evaluated. Re-evaluation
was performed between 2.5 and 3.0 years (median 2.7 years) after the first assessment.The age of the
dogs at the second evaluation ranged from 3 to 11 years (median 6 years). There were no significant
differences with regard to poor general condition or lameness between the first and the second
evaluation. At the first evaluation 22 (42%) of the Bernese Mountain dogs and 11 (37%) of the control
dogs were considered positive for antibodies against B. burgdorferi. At the second evaluation 25 (47%)
of the Bernese Mountain dogs and 12 (40%) of the control dogs were considered positive; 69% of the
dogs showed the same serological result at both examinations and 31% were seroconverted or
seroreverted. During the first examination, azotemia was diagnosed in 6 Bernese Mountain dogs and
during the second examination in 11 Bernese Mountain dogs. No control dogs had azotemia in this
study. In seropositive dogs there was no increase in lameness or signs of renal disease over time.
CONCLUSION: It may be concluded that antibodies against B. burgdorferi determined by whole cell
ELISA and confirmed by Western blot were neither associated with the development of lameness nor
with signs of renal disease like azotemia or proteinuria in dogs observed over a period of 2.5 to 3.0
years.
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Abstract
Background: Data on the long-term outcome of B. burgdorferi infections in adult dogs are sparse. The
aim of the present study was to investigate whether Bernese Mountain dogs with serological evidence of
natural B. burgdorferi infection more often develop signs such as lameness, azotemia or proteinuria during
a follow-up period of 2.5 to 3.0 years. Seropositive Bernese Mountain dogs were compared to
seronegative Bernese Mountain dogs and to seropositive and seronegative control dogs of other breeds.
Dogs included in a previous study on the prevalence of antibodies against B. burgdorferi in Bernese
Mountain dogs were re-evaluated. Antibodies against B. burgdorferi were determined using an ELISA with
a whole-cell sonicate as antigen and results were confirmed using a Western blot assay.
Results: Fifty-three Bernese Mountain dogs and 30 control dogs were re-evaluated. Re-evaluation was
performed between 2.5 and 3.0 years (median 2.7 years) after the first assessment.
The age of the dogs at the second evaluation ranged from 3 to 11 years (median 6 years). There were no
significant differences with regard to poor general condition or lameness between the first and the second
evaluation.
At the first evaluation 22 (42%) of the Bernese Mountain dogs and 11 (37%) of the control dogs were
considered positive for antibodies against B. burgdorferi. At the second evaluation 25 (47%) of the Bernese
Mountain dogs and 12 (40%) of the control dogs were considered positive; 69% of the dogs showed the
same serological result at both examinations and 31% were seroconverted or seroreverted. During the
first examination, azotemia was diagnosed in 6 Bernese Mountain dogs and during the second examination
in 11 Bernese Mountain dogs. No control dogs had azotemia in this study. In seropositive dogs there was
no increase in lameness or signs of renal disease over time.
Conclusion: It may be concluded that antibodies against B. burgdorferi determined by whole cell ELISA
and confirmed by Western blot were neither associated with the development of lameness nor with signs
of renal disease like azotemia or proteinuria in dogs observed over a period of 2.5 to 3.0 years.
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Prior serologic surveys have shown that long-term persist-
ence of B. burgdorferi-specific antibodies in dogs may
occur. However, data on the long-term outcome of said
infections in adult dogs are sparse [1,2]. In experimentally
infected young beagles recurrent lameness was observed
up to 280 days post infection [3]. In a post mortem study
lymphadenopathy was found in the area of tick attach-
ment and there were microscopical signs of inflammation
in synovial membranes, joint capsules and tendon sheets
after exposure to infected ticks [4]. Further observation
lent some support to the assumption that canine B. burg-
dorferi infection is also related to renal disease [5,6]. The
term "Lyme nephritis" was introduced to describe a renal
disease with specific renal histopathologic lesions includ-
ing immune-mediated glomerulonephritis, tubular necro-
sis and interstitial nephritis in dogs in which antibodies
against B. burgdorferi were detected [6]. Considering the
proposed pathophysiology of Lyme nephritis to be an
immune-mediated glomerular disease [6,7] one would
expect a progressive course with dogs developing disease
after chronic infection. However, experimental infection
of young Beagle dogs with B. burgdorferi sensu stricto gave
no pathologic indications of glomerular disease for up to
581 days after experimental exposure to infected ticks [4].
It was speculated that under natural conditions age, breed
or the pathological features of the borrelial agent might
influence the development of Lyme nephritis. However,
there are as yet no data on the long-term clinical outcome
of natural B. burgdorferi infections in dogs. Recent studies
partly support an interrelation between seroprevalence of
B. burgdorferi and genetic predisposition for increased sus-
ceptibility to borrelial infections in Bernese Mountain
dogs [8].
The aim of the present study was to investigate whether
Bernese Mountain dogs with serological evidence of natu-
ral B. burgdorferi infection more often develop signs such
as lameness, proteinuria or azotemia during a follow-up
period of 2.5 to 3.0 years. Seropositive Bernese Mountain
dogs were compared to seronegative Bernese Mountain
dogs, and to seropositive and seronegative control dogs of
other breeds.
Methods
Samples and dogs
Dogs included in a previous study on the prevalence of B.
burgdorferi in Bernese Mountain dogs were re-evaluated
after 2.5 years (899 days), and after 3.0 years (1113 days)
(median 2.7 years (992 days)) [8]. This study focussed on
including similar numbers of dogs of the following
groups: Bernese Mountain dogs in which antibodies
against B. burgdorferi were diagnosed, Bernese Mountain
dogs in which no antibodies against B. burgdorferi were
detected, control dogs (long haired large breed dogs but
not Bernese Mountain dogs) in which antibodies against
B. burgdorferi were diagnosed, and control dogs in which
no antibodies against B. burgdorferi were detected. For the
first study dogs were sampled between July 2002 and April
2003. There were 160 Bernese Mountain dogs and 62 con-
trol dogs. Dogs were re-evaluated between June and Octo-
ber 2005. The owners of 82 Bernese Mountain dogs and
62 control dogs evaluated in the previous study were con-
tacted a second time in order to evaluate the response over
time of clinical and laboratory parameters. For 29 Bernese
Mountain dogs (35%) and 32 control dogs (52%) no sec-
ond examination was possible because the dogs were
either dead (25 Bernese Mountain dogs and 14 control
dogs) or the owners could not be reached a second time,
or were unwilling to participate again (4 Bernese Moun-
tain dogs and 18 control dogs). The health status of the
dogs was assessed using a questionnaire filled in by the
owners. Answers relating to general health and lameness
were compared between the first and the second examina-
tion to assess possible consequences of a B. burgdorferi
infection. Owners were asked to judge if the general
health of their dog was normal or abnormal, and if their
dogs were lame or not at the time of the second evalua-
tion. At both time-points routine laboratory tests of blood
and urine samples were performed. For serologic testing
samples were frozen at minus 80°Celsius.
Haematology and serum biochemistry
Laboratory tests included a complete blood count (CBC)
and a serum biochemical analysis containing determina-
tion of bilirubin, glucose, urea, creatinine, total protein,
albumin, cholesterol, sodium, potassium, chloride, cal-
cium and phosphorus concentrations; as well as the activ-
ity of alkaline phosphatase, alanine transferase, aspartate
transferase and amylase. Hematocrit, urea, creatinine,
total protein and albumin values during the first and the
second examination were compared to assess renal func-
tion and function of the filtration barrier. Dogs were
deemed azotemic if creatinine was above 125 μmol/L
and/or if urea was above 9.4 mmol/L.
Urinalysis
Urinalysis consisted of a urine dip stick (Combur-Test,
Roche Diagnostics GmbH, Mannheim Germany), micro-
scopic examination of urine sediment, and determination
of urine specific gravity. Results of urine protein measure-
ments were considered only if fewer than 5 leukocytes per
400× field were counted in the urine sediment. The results
of the protein measurement with the dip stick were
recorded as negative or 1+ to 3+ positive. The urine pro-
tein-to-creatinine ratio (UPC) was measured on a Cobas-
Integra analyzer (Roche, Rotkreuz, Switzerland). A differ-
ence in UPC between the first and the second examination
was considered significant if it was 80% or more of the
first value [9]. Microalbuminuria was measured by a com-
mercial rapid immunoassay for canine microalbuminuria
(E.R.D.-Screen™-Test, HESKA®, Fribourg, Switzerland).Page 2 of 8
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medium-positive or high-positive according to the manu-
facturer's instructions. Urine specific gravity and results of
the measurements of protein in urine were compared
between the first and the second examination. If the dogs
were azotemic, the azotemia was considered renal if the
urine specific gravity was below 1.030.
Serologic testing
Serologic testing of serum stored at minus 80°C was per-
formed. Serologic tests of the samples of the first and the
second evaluation were performed together. An enzyme-
linked immunosorbent assay (ELISA) for the detection of
antibodies against B. burgdorferi sensu lato was performed
for all dogs according to established protocols as
described previously [8,10].
Briefly, a whole-cell sonicate of B. burgdorferi sensu stricto
reference strain B31 (ATCC 35210), B. garinii N34, B.
afzelii VS 461 and B. valaisiana VS 116 was used as antigen.
Prior to serological testing serum samples were absorbed
with a heterologous sorbant of washed formalin inacti-
vated whole cells of Escherichia coli, Salmonella typhimu-
rium, Brachispira hyodysenteriae, Bacillus subtilis and a total
of ten serovars of Leptospira (L.) interrogans and L.
borgepetersenii, respectively.
For each plate positive and negative control samples were
applied. The cut-off was calculated from the serial meas-
urement of the negative controls.
Western blot examinations to detect antibodies against B.
burgdorferi were performed using a commercial test kit
modified for dogs (Virion Ltd., Rüschlikon, Switzerland).
Tests were performed according to the manufacturer's
instructions and consisted of Western blot strips with
defined partial antigens of B. burgdorferi sensu stricto and
B. afzelii. Western blot results were interpreted according
to criteria recommended for European species of B. burg-
dorferi sensu lato [11]. Samples were called positive if
bands at the level of the partial antigens p100, p58, OspC,
p21 or wb18 were identified or if at least two bands at the
level of the partial antigens p45, bmpa und wb30 were
present. Bands at the level of the partial antigens OspB,
OspA, OspD, wb22 und OspE were considered unspecific.
Dogs were considered to have antibodies against B. burg-
dorferi if both the ELISA and the Western blot were posi-
tive.
Statistical analysis
Data was recorded and analyzed using a commercial com-
puter program (Statistical Package for the Social Sciences
for Windows version 11, SPSS Inc, Chicago Illinois, USA).
Data of the first and the second examination was com-
pared using the Wilcoxon signed rank test for ordinal data
and McNemar's change test for nominal data. Addition-
ally, to compare age between dogs with and without poor
general condition and between dogs with and without
lameness the Mann-Whitney U test was used. For dogs re-
evaluated after the first examination and those not re-eval-
uated the Mann-Whitney U test was also used for the com-
parison of hematocrit, urea, creatinine, protein, albumin,
urine specific gravity and urine protein-to creatinine ratio.
The Fisher's exact test was used to compare the occurrence
of lameness between dogs re-evaluated a second time and
those not re-evaluated. Differences were considered sig-
nificant at P < 0.05. Bonferroni correction was applied in
the comparison of haematology, serum chemistry and
urine parameters.
Results
Fifty-three Bernese Mountain dogs and 30 control dogs
were re-evaluated. The age of the dogs at the time of the
second evaluation ranged from 3 to 11 years (median 6
years). There were 23 male and 60 female dogs.
Antibodies against B. burgdorferi
At the first evaluation, 22 (42%) of the Bernese Mountain
dogs and 11 (37%) of the control dogs were considered
positive for antibodies against B. burgdorferi (Table 1). At
the second evaluation, 25 (47%) of the Bernese Mountain
dogs and 12 (40%) of the control dogs were considered
positive.
Of the Bernese Mountain dogs, 36 (68%) had the same
serological results at both examinations and 17 (32%)
either seroconverted or seroreverted. Of the control dogs,
21 (70%) had the same serological result at both exami-
nations and 9 (30%) either seroconverted or seroreverted.
There was no significant change in serological results
between the first and the second evaluation in either
group.
Answers to questionnaire
All dogs were considered healthy by their owners at the
time of the first evaluation. At the second evaluation, 8
owners stated that the general condition of their dogs had
detoriated (Table 2). Of these dogs 1 Bernese Mountain
dog and 2 control dogs were seropositive for B. burgdorferi
in both examinations, 2 control dogs were negative in
both examinations, 1 Bernese Mountain dog serocon-
verted and 1 Bernese Mountain dog and 1 control dog
seroreverted. Three of the eight dogs also showed lame-
ness at the time of the second evaluation. (2 seroreverted
and 1 remained seropositive). There were no significant
differences in the occurrence of a poor general condition
between the first and the second evaluation. However,
dogs with a poor general condition were significantly
older than those with a good general condition at the time
of the second evaluation (age 8 to 11 years, median 10
years versus 3 to 10 years, median 6 years; P < 0.001).Page 3 of 8
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examination and 10 owners reported lameness at the sec-
ond evaluation (Table 1). Of the 10 dogs lame at the sec-
ond evaluation, poor general condition was reported for 3
(2 seroreverted and 1 remained seropositive). Four of the
dogs that were lame at the first evaluation were still lame
at the second evaluation, whilst 1 seronegative Bernese
Mountain dog was no longer lame. Six dogs were newly
lame at the second evaluation (5 Bernese Mountain dogs
and 1 control dog). Five of these dogs showed antibodies
against B. burgdorferi at the first evaluation whilst 1 Ber-
nese Mountain dog proved negative. However, 2 Bernese
Mountain dogs seroreverted and were negative at the sec-
ond evaluation, whilst the other dogs kept their serologi-
cal status. There was no significant difference in the
occurrence of lameness between the first and the second
evaluation in all groups. Dogs with lameness at the sec-
ond evaluation were significantly older than the dogs that
showed no lameness (6 to 11 years, median 8 years versus
3 to 10 years, median 6 years; P < 0.005).
Table 1: Antibodies against B. burgdorferi in Bernese Mountain dogs and control dogs at the first evaluation and after a median of 2.7 
years.
First evaluation
Bernese Mountain dogs (N = 53) Control dogs
(N = 30)
B. burgdorferi serology
Serology result at the second evaluation positive
(N = 22)
negative
(N = 31)
positive
(N = 11)
negative
(N = 19)
remained negative 21 (68%) 14 (74%)
remained positive 15 (68%) 7 (64%)
seroconverted* 7 (32%) 4 (36%)
seroreverted** 10 (32%) 5 (26%)
*seroconversion: Serologic test for antibodies against B. burgdorferi was negative in the first evaluation and changed to positive in the second.
**seroreversion serologic test for antibodies against B. burgdorferi was positive in the first evaluation and changed to negative in the second.
Table 2: General condition and lameness in Bernese Mountain dogs and control dogs at the first examination and after a median of 2.7 
years.
Bernese Mountain dogs (N = 53) Control dogs (N = 30)
Result of B. burgdorferi serology at the first examination
positive (N = 22) negative (N = 31) positive (N = 11) negative (N = 19)
General condition 1st ex. normal 21 31 11 18
poor
2nd ex. normal 19 30 8 16
poor 2 1 3 2
[P = 0.5]* [P = 1.0] [P = 0.25] [P = 0.5]
Lameness 1st ex. no 21 30 10 15
yes 1 1 3
2nd ex. no 17 30 9 15
yes 4 1 2 3
[P = 0.125] [P = 1.0] [P = 1.0] [P = 1.0]
ex. = examination
*P resulting from comparison between first and second evaluationPage 4 of 8
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Results of the laboratory tests and urinalysis are shown in
Table 3. At the first examination, 6 Bernese Mountain
dogs were azotemic (creatinine 95–155 μmol/L, median
109 μmol/L; urea 7.1–13.1 mmol/L, median 10.1 mmol/
L). Renal azotemia was considered a possibility in 5 of
these dogs. At the second examination 11 Bernese Moun-
tain dogs were azotemic (creatinine 82–260 μmol/L,
median 130 μmol/L; urea 6.5–15.1 mmol/L, median 10.0
mmol/L). In 5 of these dogs renal azotemia was consid-
ered possible. No control dogs were azotemic at either
examination. Of the 6 Bernese Mountain dogs which were
azotemic at the first examination 2 were non azotemic at
the second evaluation whilst 4 remained azotemic. At the
first examination all azotemic dogs were negative for anti-
bodies against B. burgdorferi. At the second examination, 6
of the 11 dogs with azotemia were positive for antibodies
against B. burgdorferi.
Six Bernese Mountain dogs and 3 control dogs had a sig-
nificant increase in UPC between the first and the second
examination (80% or more of the first value; 0.06–0.44,
Table 3: Range and median of hematology, serum chemistry and urine parameters in Bernese Mountain dogs and control dogs at the 
first examination and after a median of 2.7 years.
Bernese Mountain dogs (N = 53) Control dogs (N = 30)
Result of B. burgdorferi serology at the first examination
Parameters Reference range positive (N = 22) negative (N = 31) positive (N = 11) negative (N = 19)
Hematocrit [%] 42–55 1st ex. 41–63 (51) 41–60 (50) 40–57 (51) 43–54 (48)
2nd ex. 36–54 (46) 36–54 (46) 34–49 (44) 41–55 (47)
[P < 0.001]* [P < 0.001]* [P = 0.004]* [P = 0.06]
Urea [mmol/L] 3.8–9.4 1st ex. 3.1–8.9 (6.7) 4.0–13.1 (6.5) 3.8–7.7 (5.6) 3.4–8.6 (5.6)
2nd ex. 3.9–13.7 (6.5) 3.6–15.1 (6.9) 2.8–6.4 (4.8) 1.7–6.7 (4.2)
[P = 0.73] [P = 0.34] [P = 0.21] [P = 0.001]*
Creatinine [μmol/L] 64–125 1st ex. 80–120 (102) 74–155 (100) 72–119 (87) 66–114 (82)
2nd ex. 64–138 (108) 65–260 (99) 59–110 (78) 52–107 (72)
[P = 0.85] [P = 0.96] [P = 0.003]* [P < 0.001]*
Protein [g/L] 56–71 1st ex. 58–74 (64) 43–74 (63) 53–65 (61) 50–67 (61)
2nd ex. 53–70 (64) 55–73 (64) 59–69 (61) 58–74 (63)
[P = 0.77] [P = 0.002]* [P = 0.28] [P = 0.02]
Albumin [g/L] 29–37 1st ex. 25–33 (30) 21–34 (30) 28–35 (32) 28–35 (31)
2nd ex. 22–36 (33) 28–38 (35) 30–40 (33) 30–40 (35)
[P = 0.001]* [P < 0.001]* [P = 0.03] [P < 0.001]*
Urine specific gravity 1st ex. 1.010–1.049 (1.030) 1.006–1.050 (1.028) 1.011–1.048 (1.021) 1.007–1.048 (1.027)
2nd ex. 1.006–1.050 (1.030) 1.007–1.050 (1.034) 1.012–1.046 (1.023) 1.006–1.042 (1.026)
[P = 0.21] [P = 0.27] [P = 0.81] [P = 0.41]
Urine protein-to-
creatinine ratio (UPC)
1st ex. 0.06–0.28 (0.11) 0.06–0.42 (0.11) 0.07–0.48 (0.12) 0.08–0.21 (0.11)
2nd ex. 0.05–0.36 (0.14) 0.06–0.44 (0.10) 0.06–0.92 (0.09) 0.06–0.53 (0.11)
[P = 0.05] [P = 0.79] [P = 0.13] [P = 0.91]
Urine protein on dip stick 1st ex. 15 neg., 3 pos. 21 neg., 5 pos. 9 neg., 2 pos. 11 neg., 6 pos
2nd ex. 6 neg., 11 pos. 7 neg., 18 pos. 4 neg., 7 pos. 9 neg., 8 pos.
[P = 0.001]* [P < 0.001]* [P = 0.03] [P = 0.27]
Micro-albuminuria test 1st ex. 11 neg., 8 pos. 22 neg., 4 pos. 10 neg. 14 neg., 3 pos.
2nd ex. 11 neg., 6 pos. 20 neg., 5 pos. 10 neg., 1 pos. 13 neg., 4 pos.
[P = 0.69] [P = 0.25] [P = 1.00] [P = 1.00]
*Significant difference between first and second examination at P < 0.006 due to Bonferroni correction.
ex. = examinationPage 5 of 8
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of the control dogs had antibodies against B. burgdorferi at
the first examination. At the second evaluation one more
Bernese Mountain dog was positive. All other dogs kept
their serologic status.
Of the 16 dogs with a positive dipstick result in the first
examination, 4 were negative in the second examination
(1 Bernese Mountain dog and 3 control dogs). A total of
21 Bernese Mountain dogs and 11 control dogs changed
from a negative dipstick result in the first examination to
a positive result in the second examination (30 dogs 1+
positive and 2+ positive). In 7 of the 32 dogs with a
change in the dipstick result positive antibodies against B.
burgdorferi were detected in the first examination and
these dogs remained positive, 13 were negative and
remained negative, 6 seroconverted and 6 seroreverted.
The difference in occurrence of a positive dipstick result
between the first and the second examination was signifi-
cant in Bernese Mountain dogs but not in control dogs.
Overall, 15 (18%) of the dogs were tested positive against
microalbuminuria during the first examination and 16
(19%) during the second test. Three dogs were low-posi-
tive in the first examination and tested negative in the sec-
ond examination. Four dogs were high-positive in both
the first and second examination. Seven dogs that were
negative during the first examination were positive during
the second exmination (5 light positive and 2 medium
positive). Of the 7 dogs in which the microalbuminuria
test changed from negative to positive, 6 were Bernese
Mountain dogs, and 1 was a control dog. In 3 of these 7
dogs antibodies against B. burgdorferi were detected dur-
ing the first examination and remained positive, 3 were
negative and remained negative and 1 seroconverted.
Comparison with dogs not evaluated a second time
Not all dogs evaluated in a previous study [8] were exam-
ined a second time. To confirm that a representative
number of the dogs evaluated the first time was selected,
different parameters of the first examination were com-
pared between these dogs and those that were not re-
examined. The only significant difference was found in
the hematocrit of seronegative control dogs. The hemat-
ocrit was higher in dogs evaluated a second time (P =
0.001), ranging from 43–54% (median 48%) in re-evalu-
ated dogs and from 35–53% (median 44%) in non re-
evaluated dogs. Seven of the dogs that were not re-evalu-
ated had a hematocrit below the reference range (42–
55%).
Discussion
The purpose of this study was to re-evaluate similar num-
bers of Bernese Mountain dogs and control dogs in which
antibodies against B. burgdorferi had been detected or not
detected in a previous study [8]. However, even though all
owners of control dogs participating in the first study were
re-contacted, we were not able to obtain as high a number
of control dogs positive for antibodies against B. burgdor-
feri as Bernese Mountain dogs. The main reason was that
owners of control dogs were not willing to participate in
the study a second time.
We were not able to obtain sufficient useful information
on relevant diseases or treatments of the dogs between the
two examinations. Accordingly, the influence of past dis-
ease problems on the current status of the dogs could not
be evaluated. However, comparing the dogs which were
re-evaluated with those that were not re-evaluated indi-
cated that a representative group of dogs from the first
study was included.
In dogs that were re-evaluated there were only minor dif-
ferences between the first and the second examination.
For some dogs owners reported a poorer general condi-
tion at the second evaluation. The unspecific parameter
might indicate non obvious health problems. This was
considered important because in human medicine non-
specific signs like persistent pain and fatigue are attributed
to "chronic Lyme disease", which is unfortunately not a
well defined term [12]. However, in most dogs poor gen-
eral condition could be attributed to age-related changes.
Lameness and fever were the only clinical findings in exper-
imentally infected dogs [13]. For this study it was assumed
that lameness would be more common in dogs that were
positive for B. burgdorferi antibodies than in other dogs.
However, this was not the case. There are several explana-
tions for this. Possibly B. burgdorferi did not cause disease in
these dogs at all, or the disease remained subclinical. In
addition, it is known that clinical signs are often intermit-
tent and lameness was assessed only at the time-points of
both examinations. The question also remains whether
European B. burgdorferi strains might cause different or no
diseases in dogs. The reports on Lyme disease in dogs orig-
inate from the United States, where only B. burgdorferi
sensu stricto are present whilst in Switzerland B. garinii pre-
dominates, followed by B. afzelii and B. burgdorferi sensu
stricto [14,15]. Furthermore, even within the species of B.
burgdorferi sensu stricto different genotypes were shown to
cause different disease severities in mice [16]. Still more
dogs which were seropositive at the first evaluation were
lame at the second evaluation; however, if B. burgdorferi was
involved in the development of lameness one would expect
persistent infection and not a seroreversion. Furthermore,
lameness due to other arthropathies is likely in old large
breed dogs. Therefore, we come to the same conclusion as
Levy and Magnarelli (1992)[17], i.e. that the serologic sta-
tus of apparently healthy dogs has no value in predicting
subsequent lameness.Page 6 of 8
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examinations, indicating that the percentage of dogs
infected might remain stable over time. This differs from a
study in an endemic area, where more dogs seroconverted
(24%) than seroreverted (9%) [17]. Different strains or
recurrent infection might be the reason for this. Interest-
ingly, in humans exposed to ticks seroreversion seems to be
more common than seroconversion [18]. Seropositivity is
also influenced by the season in which the samples are col-
lected. OD values were found to be lower during the ticks'
quiescent period than during the tick season [19]. For the
present study the first sampling was partly conducted dur-
ing the non-tick season. This might have led to fewer posi-
tive samples than during the tick-season.
There was no indication of reduced renal function in the
parameters examined. Although serum creatinine was
higher in the dogs with antibodies against B. burgdorferi,
azotemia rarely occurred. Furthermore, there were no dif-
ferences in serum urea concentrations.
The serum albumin concentration was lower in Bernese
Mountain dogs than in control dogs. This could not be
attributed to urinary loss since the degree of proteinuria in
Bernese Mountain dogs was not different from that in
other dogs. This corresponds to earlier studies in which no
higher prevalence of proteinuria was found in Bernese
Mountain dogs or Labrador Retrievers with antibodies
against B. burgdorferi [20,21]. The only significant differ-
ence with regard to protein excretion in the urine was an
increase in positive dipstick results in Bernese Mountain
dogs during the second examination. As this was the case
in both positive and negative dogs an influence of B. burg-
dorferi infection is unlikely. The slightly higher specific
gravity in the group of negative Bernese Mountain dogs
might explain some of the changes. Furthermore, most
dipstick readings changed from negative to only 1+ posi-
tive, a change that is minimal and might even depend on
the reader.
The test used to establish microalbuminuria had predicted
the development of proteinuria in dogs with X-linked
hereditary glomerulopathy [22]. This study did not reveal
a difference in microalbuminuria between the first and
the second examination. The occurrence of microalbu-
minuria was similar to another report in which 19% of the
healthy dogs showed microalbuminuria [23]. The preva-
lence of microalbuminuria has been reported to increase
with age, but in this study there were minimal increases
between the first and the second evaluation even though
the dogs were almost three years older [24].
Conclusion
It may be concluded that antibodies against B. burgdorferi
determined by whole cell ELISA and confirmed by West-
ern blot were not associated with the development of
lameness and signs of renal disease like azotemia or pro-
teinuria in dogs observed over a period of 2.5 to 3.0 years.
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